USD 16.94
(-5.88%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | 81.94 Billion JPY | 6.2% |
2023 | 77.16 Billion JPY | 5.71% |
2022 | 72.99 Billion JPY | -9.27% |
2021 | 80.45 Billion JPY | 12.49% |
2020 | 71.52 Billion JPY | 43.29% |
2019 | 49.91 Billion JPY | 516.09% |
2018 | 8.1 Billion JPY | -20.96% |
2017 | 10.25 Billion JPY | -61.38% |
2016 | 26.54 Billion JPY | -19.65% |
2015 | 33.03 Billion JPY | 22.58% |
2014 | 26.94 Billion JPY | -7.46% |
2013 | 29.12 Billion JPY | -27.5% |
2012 | 40.16 Billion JPY | 645.89% |
2011 | 5.38 Billion JPY | 69.23% |
2010 | 3.18 Billion JPY | 39.07% |
2009 | 2.28 Billion JPY | -27.43% |
2008 | 3.15 Billion JPY | -56.45% |
2007 | 7.24 Billion JPY | -32.98% |
2006 | 10.8 Billion JPY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 FY | 81.94 Billion JPY | 6.2% |
2024 Q2 | 64 Billion JPY | -3.47% |
2024 Q1 | 66.3 Billion JPY | -14.08% |
2024 Q4 | 81.94 Billion JPY | 16.9% |
2024 Q3 | 70.1 Billion JPY | 9.53% |
2023 Q3 | 56.7 Billion JPY | 2.14% |
2023 Q1 | 55.51 Billion JPY | -23.96% |
2023 Q4 | 77.16 Billion JPY | 36.09% |
2023 FY | 77.16 Billion JPY | 5.71% |
2023 Q2 | 55.51 Billion JPY | 0.0% |
2022 Q1 | 63.9 Billion JPY | -20.57% |
2022 Q3 | 61.82 Billion JPY | -2.85% |
2022 FY | 72.99 Billion JPY | -9.27% |
2022 Q2 | 63.63 Billion JPY | -0.43% |
2022 Q4 | 72.99 Billion JPY | 18.08% |
2021 Q3 | 72.46 Billion JPY | -2.45% |
2021 Q1 | 73.56 Billion JPY | 2.85% |
2021 Q4 | 80.45 Billion JPY | 11.03% |
2021 Q2 | 74.28 Billion JPY | 0.98% |
2021 FY | 80.45 Billion JPY | 12.49% |
2020 Q4 | 71.52 Billion JPY | 15.43% |
2020 FY | 71.52 Billion JPY | 43.29% |
2020 Q1 | 45.02 Billion JPY | -9.8% |
2020 Q2 | 43.75 Billion JPY | -2.81% |
2020 Q3 | 61.96 Billion JPY | 41.6% |
2019 Q1 | 47.29 Billion JPY | 483.79% |
2019 Q2 | 35 Billion JPY | -26.0% |
2019 Q4 | 49.91 Billion JPY | 3.67% |
2019 FY | 49.91 Billion JPY | 516.09% |
2019 Q3 | 48.15 Billion JPY | 37.56% |
2018 Q2 | 5.29 Billion JPY | -15.88% |
2018 FY | 8.1 Billion JPY | -20.96% |
2018 Q4 | 8.1 Billion JPY | 52.93% |
2018 Q3 | 5.29 Billion JPY | 0.0% |
2018 Q1 | 6.29 Billion JPY | -38.56% |
2017 Q2 | 19.29 Billion JPY | -4.93% |
2017 FY | 10.25 Billion JPY | -61.38% |
2017 Q3 | 17.29 Billion JPY | -10.36% |
2017 Q1 | 20.29 Billion JPY | -23.52% |
2017 Q4 | 10.25 Billion JPY | -40.74% |
2016 Q2 | 25.3 Billion JPY | -19.17% |
2016 Q4 | 26.54 Billion JPY | 13.91% |
2016 Q3 | 23.3 Billion JPY | -7.91% |
2016 FY | 26.54 Billion JPY | -19.65% |
2016 Q1 | 31.3 Billion JPY | -5.25% |
2015 Q2 | 20.25 Billion JPY | -0.12% |
2015 Q1 | 20.27 Billion JPY | -24.76% |
2015 Q3 | 18.25 Billion JPY | -9.88% |
2015 Q4 | 33.03 Billion JPY | 81.01% |
2015 FY | 33.03 Billion JPY | 22.58% |
2014 Q1 | 24.44 Billion JPY | -16.05% |
2014 FY | 26.94 Billion JPY | -7.46% |
2014 Q3 | 22.3 Billion JPY | -8.57% |
2014 Q4 | 26.94 Billion JPY | 20.84% |
2014 Q2 | 24.39 Billion JPY | -0.23% |
2013 Q3 | 33.38 Billion JPY | 9.29% |
2013 Q4 | 29.12 Billion JPY | -12.77% |
2013 FY | 29.12 Billion JPY | -27.5% |
2013 Q1 | 35.6 Billion JPY | -11.37% |
2013 Q2 | 30.54 Billion JPY | -14.19% |
2012 FY | 40.16 Billion JPY | 645.89% |
2012 Q2 | 2.92 Billion JPY | -9.9% |
2012 Q3 | 42.81 Billion JPY | 1365.4% |
2012 Q4 | 40.16 Billion JPY | -6.2% |
2012 Q1 | 3.24 Billion JPY | -39.78% |
2011 Q1 | 4.02 Billion JPY | 26.52% |
2011 FY | 5.38 Billion JPY | 69.23% |
2011 Q2 | 3.96 Billion JPY | -1.61% |
2011 Q3 | 3.84 Billion JPY | -3.03% |
2011 Q4 | 5.38 Billion JPY | 40.2% |
2010 Q2 | 1.11 Billion JPY | 0.0% |
2010 FY | 3.18 Billion JPY | 39.07% |
2010 Q4 | 3.18 Billion JPY | 299.75% |
2010 Q3 | 796 Million JPY | -28.8% |
2009 Q3 | 2.15 Billion JPY | 0.0% |
2009 Q4 | 2.28 Billion JPY | 6.22% |
2009 FY | 2.28 Billion JPY | -27.43% |
2008 FY | 3.15 Billion JPY | -56.45% |
2007 FY | 7.24 Billion JPY | -32.98% |
2006 FY | 10.8 Billion JPY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Bio Medica Corporation | 2.24 Million USD | -3658158.929% |
Arrayit Corporation | 1.07 Million USD | -7600299.567% |
Atlantic International Corp. | 2.93 Million USD | -2796192.903% |
Biocept, Inc. | 12.1 Million USD | -676628.054% |
Bioqual, Inc. | 3.58 Million USD | -2284409.135% |
CardioGenics Holdings Inc | 72.61 Thousand USD | -112850039.092% |
DermTech, Inc. | 54.39 Million USD | -150550.807% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | -17266.061% |
HTG Molecular Diagnostics, Inc. | 4.83 Million USD | -1695098.211% |
iMD Companies, Inc. | 1.12 Million USD | -7315444.628% |
IDenta Corp. | 789.14 Thousand USD | -10383910.056% |
Interpace Biosciences, Inc. | 11.19 Million USD | -732074.768% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | 43.84 Thousand USD | -186896923.606% |
Lumos Diagnostics Holdings Limited | 8.04 Million USD | -1018493.859% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 3.82 Million USD | -2141754.575% |
NovelStem International Corp. | 3.57 Million USD | -2292324.969% |
Optigenex Inc. | 8.94 Million USD | -916435.283% |
PharmChem, Inc. | 77.35 Thousand USD | -105936321.341% |
Proteome Sciences plc | 17.15 Million USD | -477611.044% |
Response Genetics, Inc | 6.37 Million USD | -1285715.158% |
Rennova Health, Inc. | 15.32 Million USD | -534462.888% |
RushNet, Inc. | 4.82 Million USD | -1698911.01% |
ScreenPro Security Inc. | 207.03 Thousand USD | -39580355.384% |
Stella Diagnostics Inc. | 6.2 Million USD | -1321447.539% |
StageZero Life Sciences Ltd. | 1.8 Million USD | -4552190.089% |
Todos Medical Ltd. | 38.34 Million USD | -213587.806% |